Activists at AIDS2024 demand: Break Gilead’s Lenacapavir monopoly
Gilead’s Price is 1,000 Times the Target Generic Price for 100% Effective Prevention Shot Munich, 23 July 2024: Today at the International AIDS Conference, a coalition of activists, including Médecins Sans Frontières (MSF), called for immediate global action to break Gilead’s monopoly on lenacapavir, in response to new data showing that generic lenacapavir can be … Read more